Buscar resultados de ensayos clínicos
Abdominal Neoplasms - 350 Studies Found
| Estado | Estudiar |
| Active, not recruiting |
Nombre del estudio: MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer Condición:
|
| Terminated |
Nombre del estudio: Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction Condición:
|
| Active, not recruiting |
Nombre del estudio: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Condición:
|
| Active, not recruiting |
Nombre del estudio: Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182 Condición:
|
| Completed |
Nombre del estudio: LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer Condición:
Fecha: 2009-11-09 Intervenciones:
|
| Active, not recruiting |
Nombre del estudio: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer Condición:
|
| Completed |
Nombre del estudio: Comparing Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Condición:
|
| Active, not recruiting |
Nombre del estudio: Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Condición:
|
| Completed |
Nombre del estudio: Study of Paclitaxel in Patients With Ovarian Cancer Condición:
|
| Completed |
Nombre del estudio: Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condición:
|